Weichun Guo

468 total citations
30 papers, 369 citations indexed

About

Weichun Guo is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Weichun Guo has authored 30 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 16 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Weichun Guo's work include Cancer-related molecular mechanisms research (12 papers), MicroRNA in disease regulation (6 papers) and Sarcoma Diagnosis and Treatment (6 papers). Weichun Guo is often cited by papers focused on Cancer-related molecular mechanisms research (12 papers), MicroRNA in disease regulation (6 papers) and Sarcoma Diagnosis and Treatment (6 papers). Weichun Guo collaborates with scholars based in China, United Kingdom and Ethiopia. Weichun Guo's co-authors include Ling Yu, Kezhou Xia, Jun Yan, Haijuan Liu, Tian Gao, Jian Yang, Di Zheng, Zhengpei Zhang, Jin Tang and Guo Dai and has published in prestigious journals such as Scientific Reports, Biomedicine & Pharmacotherapy and BMC Cancer.

In The Last Decade

Weichun Guo

28 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weichun Guo China 13 213 153 79 57 50 30 369
Emanuele Panatta Italy 15 320 1.5× 177 1.2× 141 1.8× 44 0.8× 42 0.8× 20 509
Alessia Brossa Italy 14 402 1.9× 165 1.1× 87 1.1× 68 1.2× 44 0.9× 22 598
Agnese Di Rocco United States 12 282 1.3× 105 0.7× 115 1.5× 84 1.5× 26 0.5× 13 447
Saar Vandekeere Belgium 3 282 1.3× 204 1.3× 37 0.5× 29 0.5× 68 1.4× 4 465
Isaac Rosa Spain 14 288 1.4× 91 0.6× 63 0.8× 61 1.1× 45 0.9× 20 556
Fangzhu Wan China 11 291 1.4× 186 1.2× 143 1.8× 55 1.0× 40 0.8× 17 492
Junwei Fan China 8 250 1.2× 103 0.7× 59 0.7× 46 0.8× 25 0.5× 13 392
Jengmin Kang South Korea 12 307 1.4× 126 0.8× 56 0.7× 30 0.5× 75 1.5× 17 450
Carla Visciano Italy 5 195 0.9× 65 0.4× 149 1.9× 53 0.9× 31 0.6× 5 447
Chiara Verdelli Italy 15 284 1.3× 108 0.7× 148 1.9× 33 0.6× 40 0.8× 38 563

Countries citing papers authored by Weichun Guo

Since Specialization
Citations

This map shows the geographic impact of Weichun Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weichun Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weichun Guo more than expected).

Fields of papers citing papers by Weichun Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weichun Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weichun Guo. The network helps show where Weichun Guo may publish in the future.

Co-authorship network of co-authors of Weichun Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Weichun Guo. A scholar is included among the top collaborators of Weichun Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weichun Guo. Weichun Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Xia, Kezhou, et al.. (2024). CGREF1 modulates osteosarcoma proliferation by regulating the cell cycle through the Wnt/β-catenin signaling pathway. Molecular Medicine. 30(1). 260–260. 2 indexed citations
3.
Xia, Kezhou, et al.. (2023). SERPINH1 enhances the malignancy of osteosarcoma via PI3K-Akt signaling pathway. Translational Oncology. 39. 101802–101802. 9 indexed citations
4.
Ye, Jia, et al.. (2022). Long non-coding RNA NR2F2-AS1 regulates human osteosarcoma growth and metastasis through miR-425-5p-mediated HMGB2. International Journal of Clinical Oncology. 27(12). 1891–1903. 3 indexed citations
5.
Guo, Weichun, et al.. (2022). TIAM2 promotes proliferation and invasion of osteosarcoma cells by activating the JAK2/STAT3 signaling pathway. Journal of bone oncology. 37. 100461–100461. 4 indexed citations
6.
7.
Wang, Yonggang, et al.. (2022). XIST sponges miR-320d to promote chordoma progression by regulating ARF6. Journal of bone oncology. 35. 100447–100447. 2 indexed citations
8.
Liu, Yang, et al.. (2021). miR-1270 enhances the proliferation, migration, and invasion of osteosarcoma <em>via</em> targeting cingulin. European Journal of Histochemistry. 65(4). 11 indexed citations
9.
Zheng, Di, Kezhou Xia, Ling Yu, et al.. (2021). A Novel Six Metastasis-Related Prognostic Gene Signature for Patients With Osteosarcoma. Frontiers in Cell and Developmental Biology. 9. 699212–699212. 17 indexed citations
10.
Shi, Yubo, Weichun Guo, & Ling Yu. (2021). [Non-specific low back pain: interpretation of North American Spine Society (NASS) guidelines for evidence-based medicine].. PubMed. 35(10). 1336–1340. 5 indexed citations
11.
Yu, Ling, et al.. (2020). <p>LncRNA PLAC 2 Is Downregulated in Osteosarcoma and Regulates Cancer Cell Proliferation Through miR-93</p>. Cancer Management and Research. Volume 12. 3623–3629. 1 indexed citations
12.
Yu, Ling, Kezhou Xia, Tian Gao, et al.. (2019). The Notch Pathway Promotes Osteosarcoma Progression through Activation of Ephrin Reverse Signaling. Molecular Cancer Research. 17(12). 2383–2394. 31 indexed citations
13.
Luo, Yue, Tao Hai, Jin Lin, Wei Xiang, & Weichun Guo. (2019). CDKN2B-AS1 Exerts Oncogenic Role in Osteosarcoma by Promoting Cell Proliferation and Epithelial to Mesenchymal Transition. Cancer Biotherapy and Radiopharmaceuticals. 35(1). 58–65. 12 indexed citations
14.
Li­, ­Jun, Weichun Guo, Shuangjie Zhang, et al.. (2017). Erythropoietin facilitates the recruitment of bone marrow mesenchymal stem cells to sites of spinal cord injury. Experimental and Therapeutic Medicine. 13(5). 1806–1812. 16 indexed citations
15.
Yan, Jun, Haijuan Liu, Weichun Guo, & Jian Yang. (2017). Low serum concentrations of Irisin are associated with increased risk of hip fracture in Chinese older women. Joint Bone Spine. 85(3). 353–358. 48 indexed citations
16.
Guo, Xiaodong, Ling Yu, Zhengpei Zhang, et al.. (2017). miR-335 negatively regulates osteosarcoma stem cell-like properties by targeting POU5F1. Cancer Cell International. 17(1). 29–29. 36 indexed citations
17.
Zhang, Yan, Shuo Fang, Peng Ji, et al.. (2016). Construction of recombinant pEGFP-N1-hPer2 plasmid and its expression in osteosarcoma cells. Oncology Letters. 11(4). 2768–2772. 3 indexed citations
18.
Zhang, Yan, Shuo Fang, Peng Ji, et al.. (2015). Construction of a plasmid for overexpression of human circadian gene period2 and its biological activity in osteosarcoma cells. Tumor Biology. 36(5). 3735–3743. 14 indexed citations
19.
Zhang, Bo, Weichun Guo, Ling Yu, et al.. (2013). Cobalt chloride inhibits tumor formation in osteosarcoma cells through upregulation of HIF-1α. Oncology Letters. 5(3). 911–916. 7 indexed citations
20.
Yu, Ling, Shiqing Liu, Weichun Guo, et al.. (2012). Upregulation of Mad2 facilitates in vivo and in vitro osteosarcoma progression. Oncology Reports. 28(6). 2170–2176. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emanuele Panatta Breakdown of academic impact, for papers by Alessia Brossa Breakdown of academic impact, for papers by Agnese Di Rocco Breakdown of academic impact, for papers by Saar Vandekeere Breakdown of academic impact, for papers by Isaac Rosa Breakdown of academic impact, for papers by Fangzhu Wan Breakdown of academic impact, for papers by Junwei Fan Breakdown of academic impact, for papers by Jengmin Kang Breakdown of academic impact, for papers by Carla Visciano Breakdown of academic impact, for papers by Chiara Verdelli
Rankless by CCL
2026